Key terms
About NVAX
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest NVAX news
May 13
3:58pm ET
Novavax (NASDAQ:NVAX) Explodes Upward 50% After Sanofi Deal
May 13
11:45am ET
Novavax call volume above normal and directionally bullish
May 13
11:18am ET
Biotech Alert: Searches spiking for these stocks today
May 13
7:23am ET
Novavax price target raised to $10 from $5 at TD Cowen
May 10
12:34pm ET
BofA upgrades Novavax to Neutral on ‘best outcome’ Sanofi pact
May 10
12:29pm ET
Novavax upgraded to Neutral from Underperform at BofA
May 10
11:05am ET
Buy Rating for Novavax Amid Strategic Sanofi Partnership and Solid Financial Prospects
May 10
10:56am ET
H.C. Wainwright reiterates Buy rating on Novavax after ‘landmark’ Sanofi deal
May 10
9:46am ET
NVAX Earnings: Novavax Soars After Mixed Q1, Sanofi Deal Boost
May 10
9:24am ET
Novavax upgraded to Neutral from Underweight at JPMorgan
May 10
7:05am ET
Options Volatility and Implied Earnings Moves Today, May 10, 2024
May 10
5:18am ET
Novavax, Sanofi enter co-exclusive COVID-19 vaccine licensing agreement
May 10
5:13am ET
Novavax to initiate additional cost reduction program
May 10
5:12am ET
Novavax cuts FY24 revenue view to $400M-$600M from $800M-$1B
May 10
5:07am ET
Novavax reports Q1 EPS ($1.05), consensus ($1.06)
May 06
6:28am ET
Novavax stockholder Shah Capital issues letter against board re-election
Apr 26
2:21pm ET
Novavax prepared to deliver JN.1 COVID vaccine in line with WHO recommendation
Apr 15
6:06am ET
Shah Capital recommends to appoint two new directors to Novavax board
Apr 15
5:48am ET
Novavax (NASDAQ:NVAX) Jumps Amid Activist Investor Push
Apr 01
8:04am ET
Novavax reports data on updated COVID-19 vaccine
Mar 28
9:35pm ET
Upcoming Deadline to Share in Novavax, Inc. (NVAX) Class Action Settlement
Mar 26
4:07pm ET
Novavax discloses confidential settlement agreement with Fujifilm
Mar 19
12:19am ET
Novavax (NASDAQ:NVAX): A Highly Speculative Value Trade in the Post-Pandemic Era
Mar 11
9:10am ET
Novavax notes Canada’s National Advisory Committee on Immunization guidance
Mar 01
6:25am ET
Novavax price target lowered to $19 from $35 at H.C. Wainwright
Feb 29
11:25am ET
Novavax call volume above normal and directionally bullish
Feb 29
8:16am ET
Optimistic Outlook for Novavax: Strategic Plans and Financial Health Signal Market Share Growth Potential
Feb 28
9:55pm ET
Maintaining Hold on Novavax: Assessing Current Performance and Future Market Penetration Strategies
Feb 28
3:58pm ET
Novavax says CDC advisors in favor of added COVID vaccine dose for 65 and older
Feb 28
8:04am ET
Novavax sees FY24 revenue $800M-$1.000B, consensus $969.56M
Feb 28
8:02am ET
Novavax reports Q4 EPS ($1.44), consensus (45c)
Yesterday
12:30pm ET
Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement
May 07
12:15pm ET
Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement
May 02
12:30pm ET
Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement
Apr 25
12:30pm ET
Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement
Apr 18
12:15pm ET
Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement
Apr 16
12:30pm ET
Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement
Apr 11
12:30pm ET
Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement
Apr 09
12:30pm ET
Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement
NVAX Financials
Key terms
Ad Feedback
NVAX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
NVAX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range